2 results
Approved WMOCompleted
This study is designed to investigate the limiting effect on infarct size of high dose intravenous adenosine during primary angioplasty
Approved WMOCompleted
The objective of this open label phase IIa trial is to evaluate the efficacy and tolerability of a once a week dose of 200 mg R126638, for a maximum of 12 weeks, for the treatment of toenail onychomycosis.